期刊文献+

鲍曼不动杆菌血流感染危险因素分析 被引量:2

Risk Factors of Acinetobacter Baumannii Bloodstream Infection
下载PDF
导出
摘要 目的探讨鲍曼不动杆菌血流感染的危险因素。方法选取某三甲医院2015年2月至2020年6月收治的鲍曼不动杆菌血流感染患者40例,根据30 d预后情况将患者分为死亡组(16例)和存活组(24例),根据耐药情况分为耐碳青霉烯类鲍曼不动杆菌(CRAB)组(28例)和碳青霉烯类敏感鲍曼不动杆菌(CSAB)组(12例),通过医院电子病历信息系统收集患者的基本信息、临床和实验室检查结果、基础疾病、微生物学数据、入住重症监护病房(ICU)时间、血流感染前侵入性操作、抗菌药物暴露、Pitt菌血症评分(PBS)、30 d全因死亡率、经验性治疗方案、目标性治疗方案。采用单因素COX回归分析鲍曼不动杆菌血流感染患者30 d死亡的危险因素,采用Logistic回归分析CRAB血流感染的危险因素,采用Kaplan-Meier曲线和时序检验比较CRAB组和CSAB组死亡率。结果使用糖皮质激素[HR=3.3,95%CI(1.2,9.2),P=0.020],PBS高[HR=1.4,95%CI(1.1,1.7),P=0.002],脓毒性休克[HR=86.0,95%CI(1.5,5072.8),P=0.030],不恰当经验性治疗[HR=8.9,95%CI(1.2,67.4),P=0.04]均显著影响鲍曼不动杆菌血流感染患者30 d的死亡率;侵入性操作[OR=19.3,95%CI(1.9,192.8),P=0.01],入住ICU[OR=25.0,95%CI(4.2,147.1),P<0.01],入住ICU时间长[OR=1.1,95%CI(1.0,1.2),P=0.04],抗菌药物暴露[OR=65.0,95%CI(8.0,526.2),P<0.01],PBS高[OR=2.1,95%CI(1.3,3.4),P<0.01]均对CRAB血流感染患者影响显著。结论鲍曼不动杆菌血流感染患者的病死率高,感染前使用糖皮质激素、感染时PBS高、合并脓毒性休克、不恰当经验性治疗提示不良预后,侵入性操作、入住ICU且时间长、抗菌药物暴露、PBS高与发生CRAB相关。 Objective To investigate the risk factors of Acinetobacter baumannii bloodstream infection.Methods Forty patients with Acinetobacter baumannii bloodstream infection admitted to a tertiary A hospital from February 2015 to June 2020 were selected and divided into the death group(16 cases)and the survival group(24 cases)according to the 30 d-prognosis condition,and they were divided into the carbapenem-resistant Acinetobacter baumannii(CRAB)group(28 cases)and the carbapenem-susceptible Acinetobacter baumannii(CSAB)group(12 cases)according to the drug resistance.The basic information,clinical and laboratory examination results,underlying disease,microbiological data,admission time in intensive care unit(ICU),invasive manipulation before bloodstream infection,antibacterial drug exposure,Pitt bacteremia score(PBS),all-cause mortality in 30 d,empirical treatment plan and targeted treatment plan of patients in the hospital electronic medical record information system were collected.The risk factors of 30 d-mortality of patients with Acinetobacter baumannii bloodstream infection were analyzed by the univariate COX regression analysis,the risk factors of CRAB bloodstream infection were analyzed by the Logistic regression analysis,the mortalities of CRAB group and CSAB group were compared by the Kaplan-Meier(K-M)curve and log-rank test.Results The use of glucocorticoids[HR=3.3,95%CI(1.2,9.2),P=0.020],high PBS[HR=1.4,95%CI(1.1,1.7),P=0.002],septic shock[HR=86.0,95%CI(1.5,5072.8),P=0.030]and inappropriate empirical treatment[HR=8.9,95%CI(1.2,67.4),P=0.04]had significant effects on the 30 d-mortality of patients with Acinetobacter baumannii bloodstream infection.Invasive manipulation[OR=19.3,95%CI(1.9,192.8),P=0.01],admission in ICU[OR=25.0,95%CI(4.2,147.1),P<0.01],prolonged ICU stay[OR=1.1,95%CI(1.0,1.2),P=0.04],antibacterial drug exposure[OR=65.0,95%CI(8.0,526.2),P<0.01]and high PBS[OR=2.1,95%CI(1.3,3.4),P<0.01]had significant effects on patients with CRAB bloodstream infection.Conclusion The mortality of patients with Acinetobacter baumannii bloodstream infection is high.The use of glucocorticoids before infection,high PBS during infection,with septic shock and inappropriate empirical treatment suggest poor prognosis.Invasive manipulation,prolonged ICU stay,antibacterial drug exposure and high PBS are associated with the incidence of CRAB.
作者 孔文强 周义录 刘晓冬 张肃川 KONG Wenqiang;ZHOU Yilu;LIU Xiaodong;ZHANG Suchuan(Zigong First People's Hospital,Zigong,Sichuan,China 643000)
出处 《中国药业》 CAS 2022年第9期121-125,共5页 China Pharmaceuticals
基金 四川省自贡市科学技术局2020年第一批市级重点科技计划项目[2020RKX04]。
关键词 鲍曼不动杆菌 血流感染 碳青霉烯类 抗菌药物 危险因素 Acinetobacter baumannii bloodstream infection carbapenem antibacterial drug risk factor
  • 相关文献

参考文献1

二级参考文献20

  • 1Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen [ J ]. Clin Microbiol Rev, 2008, 21 (3) :538-582.
  • 2Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia [ J]. J Antimicrob Chemother, 2007, 59 (3):525-530.
  • 3Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing [ S ]. Sixteenth Informational Supplement,2009, M100-S19.
  • 4Molina J, Cisneros JM, Fern(andez-Cuenca F, et al. Clinical features of infections and colonization by Acinetobacter genospecies 3 [Jl. J Clin Microbio] ,2010,48(12) :4623-4626.
  • 5Shete VB, Ghadage DP, Muley VA, et al. Acinetobacter septicemia in neonates admitted to intensive care units [ J ]. J Lab Physicians, 2009, 1 (2) :73-76.
  • 6Huang ST, Chiang MC, Kuo SC,et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia[ J ]. J Microbiol Immunol Infect, 2012,45 (5) :356-362.
  • 7Lee NY, Chang TC, Wu CJ, et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of mononficrobial Aeinetobaeter baumannii complex bacteremia[ J]. J Infect, 2010, 61 (3) :219-227.
  • 8Fitzpatrick MA, Ozer E, Bolon MK, et al. Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidmg resistance [ J ]. J Infect, 2015, 70 ( 2 ) : 144-152.
  • 9Kim Y J, Kim SI, Hong KW, et al. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy [ J ]. J Korean Med Sci, 2012, 27(5):471-475.
  • 10Hung MH, Hsueh PR, Chang HT, et al. In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data [ J 1. Int J Antimicrob Agents,2007,29 (2) : 145-152.

共引文献45

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部